Assessing Serum Pepsinogen and Tests for Detecting Diffuse-Type Gastric Cancer: Insights from a Large-Scale and Propensity-Score-Matched Study in Republic of Korea.
The incidence of cancer and its associated mortality have increased over the past several decades [...].
APA
Lim SH, Kim N, et al. (2025). Assessing Serum Pepsinogen and Tests for Detecting Diffuse-Type Gastric Cancer: Insights from a Large-Scale and Propensity-Score-Matched Study in Republic of Korea.. Cancers, 17(6). https://doi.org/10.3390/cancers17060955
MLA
Lim SH, et al.. "Assessing Serum Pepsinogen and Tests for Detecting Diffuse-Type Gastric Cancer: Insights from a Large-Scale and Propensity-Score-Matched Study in Republic of Korea.." Cancers, vol. 17, no. 6, 2025.
PMID
40149291
Abstract
The incidence of cancer and its associated mortality have increased over the past several decades [...].
같은 제1저자의 인용 많은 논문 (5)
- Mass cytometry uncovers distinct blood myeloid phenotypes linked to clinical responses during gastric cancer chemoimmunotherapy.
- Distinct Spatially Resolved Tumor Microenvironment Trajectories Define Benefit from Ramucirumab plus Pembrolizumab in Refractory PD-L1+ Gastric Cancer.
- The Role of Serum Pepsinogen Tests for Detecting Gastric Cancer Between Sexes and Among Age Groups.
- Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial.
- Dynamic modulation of claudin18.2 expression and remodeling of the tumor microenvironment in gastric cancer during chemo-immunotherapy.